deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03464942

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer (AZTEC)

A Randomised Phase II Trial Comparing the Efficacy of Single-fraction or Multi-fraction SABR (Stereotactic Ablative Body Radiotherapy) With AteZolizumab in Patients With Advanced Triple nEgative Breast Cancer

Sponsor: Peter MacCallum Cancer Centre, Australia

Conditions Breast Cancer
Interventions Atezolizumab SABR
Updated 9 times since 2018 Last updated: Jul 17, 2023 Started: Aug 1, 2018 Primary completion: Jun 22, 2023 Completion: Jun 22, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03464942, this PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by Peter MacCallum Cancer Centre, Australia, it has been updated 9 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotNot Yet Recruiting~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~Jun 2022 · 15 months · monthly snapshotRecruiting~Jun 2022 – ~Aug 2023 · 14 months · monthly snapshotActive Not Recruiting~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Aug 2023 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jun 2022 — Aug 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Mar 2021 — Jun 2022 [monthly]

    Recruiting PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  2. Jul 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jun 2018 — Jul 2019 [monthly]

    Not Yet Recruiting PHASE2

  4. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Peter MacCallum Cancer Centre, Australia
  • Trans Tasman Radiation Oncology Group
Data source: Peter MacCallum Cancer Centre, Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations